Does the Prevalence of Dyslipidemias Differ between Newfoundland and the Rest of Canada? Findings from the Electronic Medical Records of the Canadian Primary Care Sentinel Surveillance Network

Frontiers in Cardiovascular Medicine

Volumn 2, Issue , 2015, Pages

  Asghari, Shabnam ^a   Aref Eshghi, Erfan ^a   Hurley, Oliver ^a   Godwin, Marshall ^a   Duke, Pauline ^a   Williamson, Tyler ^b   Mahdavian, Masoud ^c  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Canada; Canadian Primary Care Sentinel Surveillance Network; dyslipidemia; lipid profile; Newfoundland; prevalence

Indexed keywords

EID: 85079398917     PISSN: None     EISSN: 2297055X     Source Type: Journal    
DOI: 10.3389/fcvm.2015.00001     Document Type: Article

References (39)

1. World Health Organization (2011). Global Status Report on Noncommunicable Diseases 2010. Available from: http://whqlibdoc.who.int/publications/2011/9789240686458_eng.pdf?ua=1
2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med (2006) 3(11):e442.10.1371/journal.pmed.003044217132052
3. WHO. The Global Burden of Disease. Geneva: World Health Organization (2008).
4. Melanie N, Nick T, Peter S, Mike R. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J (2014) 35(42):2950–9.10.1093/eurheartj/ehu29925139896
5. Public Health Agency of Canada, Canadian Institute for Health Information, Heart and Stroke Foundation of Canada, Statistics Canada. Tracking Heart Disease and Stroke in Canada (2009). Available from: http://www.phac-aspc.gc.ca/publicat/2009/cvd-avc/pdf/cvd-avs-2009-eng.pdf
6. Filate WA, Johansen HL, Kennedy CC, Tu JV. Regional variations in cardiovascular mortality in Canada. Can J Cardiol (2003) 19(11):1241–8.14571309
7. Manuel DG, Leung M, Nguyen K, Tanuseputro P, Johansen K. Burden of cardiovascular disease in Canada. Can J Cardiol (2003) 19(9):997–1004.
8. Statistics Canada. Mortality, Summary List of Causes (2007). Available from: http://www.statcan.gc.ca/pub/84f0209x/84f0209x2007000-eng.htm
9. Jenum AK, Stensvold I, Thelle DS. Differences in cardiovascular disease mortality and major risk factors between districts in Oslo; An ecological analysis. Int J Epidemiol (2001) 30(Suppl 1):S59.10.1093/ije/30.suppl_1.S5911759854
10. Gupta R, Guptha S, Sharma KK, Gupta A, Deedwania P. Regional variations in cardiovascular risk factors in India: India heart watch. World J Cardiol (2012) 4(4):112.10.4330/wjc.v4.i4.11222558490
11. Musunuru K. Atherogenic dyslipidemia: cardiovascular risk and dietary intervention. Lipids (2010) 45(10):907–14.10.1007/s11745-010-3408-120524075
12. Faisal AW, Ayub M, Waseem T, Khan RS, Hasnain SS. Risk factors in young patients of acute myocardial infarction. J Ayub Med Coll Abbottabad (2011) 23(3):10–3.23272424
13. Schaefer EJ. Diagnosis and management of lipoprotein disorders. In: Rifkind BM, editor. Drug Treatment of Hyperlipidemia. New York, NY: Dekker (1991). p. 17–52.
14. Rahman P, Jones A, Curtis J, Bartlett S, Peddle L, Fernandez BA, et al. The Newfoundland population: a unique resource for genetic investigation of complex diseases. Hum Mol Genet (2003) 12:R167–72.10.1093/hmg/ddg25712915452
15. Fodor JG, Balram BC, Heyden S. Lipid and lipoprotein levels of Newfoundland school children. Ann Nutr Metab (1987) 31(4):231–6.10.1159/0001772733619404
16. Chockalingam A, Fodor JG. Cardiovascular risk factors in Newfoundland population and modification of their level through nonpharmacological intervention. J Cardiovasc Pharmacol (1990) 16(Suppl 8):S54–6.10.1097/00005344-199006168-000211706033
17. Justin O, Shabnam A, Marshall G, Kayla C, Kris A. Prevalence of dyslipidemia in Newfoundland adults: approaches to estimation using electronic medical records. J Epidemiol Community Health (2013) 67:e1.10.1136/jech-2013-202386.4
18. Birtwhistle R, Keshavjee K, Lambert-Lanning A, Godwin M, Greiver M, Manca D, et al. Building a pan-Canadian primary care sentinel surveillance network: initial development and moving forward. J Am Board Fam Med (2009) 22(4):412–22.10.3122/jabfm.2009.04.09008119587256
19. Devine S, West S, Andrews E, Tennis P, Hammad TA, Eaton S, et al. The identification of pregnancies within the general practice research database. Pharmacoepidemiol Drug Saf (2010) 19(1):45–50.10.1002/pds.186219823973
20. Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, et al. Canadian cardiovascular society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations. Can J Cardiol (2009) 25(10):567–79.10.1016/S0828-282X(09)70715-919812802
21. Cannon CP. High-density lipoprotein cholesterol as the Holy Grail. JAMA (2011) 306(19):2153–5.10.1001/jama.2011.1687
22. Statistics Canada. Canadian Health Measures Survey - Cholesterol Levels of Canadians, 2009 to 2011 (2014). Available from: http://www.statcan.gc.ca/pub/82-625-x/2012001/article/11732-eng.htm
23. Heart Health and Cholesterol Levels of Canadians, 2007 to 2009; Component of Statistics Canada Catalogue no. 82-625-X Health Fact Sheets. (2010). Available from: http://www.statcan.gc.ca/pub/82-625-x/2010001/article/11136-eng.pdf
24. Population and Dwelling Counts, for Canada, Census Metropolitan Areas, Census Agglomerations and Census Subdivisions (Municipalities), 2011 and 2006 Censuses. Statistics Canada (2014). Available from: http://www12.statcan.gc.ca/census-recensement/2011/dp-pd/hlt-fst/pd-pl/Table-Tableau.cfm?LANG=Eng&T=203&CMA=001&S=0&O=D&RPP=25
25. Lindroth M, Lundqvist R, Lilja M, Eliasson M. Cardiovascular risk factors differ between rural and urban Sweden: the 2009 Northern Sweden MONICA cohort. BMC Public Health (2014) 14(1):825.10.1186/1471-2458-14-82525106746
26. Kadhim-Saleh A, Green M, Williamson T, Hunter D, Birtwhistle R. Validation of the diagnostic algorithms for 5 chronic conditions in the Canadian primary care sentinel surveillance network (CPCSSN): a Kingston practice-based research network (PBRN) report. J Am Board Fam Med (2013) 26(2):159–67.10.3122/jabfm.2013.02.12018323471929
27. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the general practice research database: a systematic review. Br J Clin Pharmacol (2010) 69(1):4–14.10.1111/j.1365-2125.2009.03537.x20078607
28. Gulliford MC, Charlton J, Ashworth M, Rudd AG, Toschke AM, eCRT Research Team. Selection of medical diagnostic codes for analysis of electronic patient records. Application to stroke in a primary care database. PLoS One (2009) 4(9):e7168.10.1371/journal.pone.000716819777060
29. Jones PH, Nair R, Thakker KM. Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis. J Am Heart Assoc (2012) 1:e001800.10.1161/JAHA.112.00180023316314
30. Mantel-Teeuwisse AK, Kloosterman JM, Maitland-van der Zee AH, Klungel OH, Porsuis AJ, de Boer A. Drug-induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels. Drug Safety (2001) 24(6):433–56.10.2165/00002018-200124060-0000311368251
31. Chan KS, Fowles JB, Weiner JP. Electronic health records and reliability and validity of quality measures: a review of the literature. Med Care Res Rev (2010) 67(5):503–27.10.1177/107755870935900720150441
32. Tu K, Mitiku TF, Ivers NM, Guo H, Lu H, Jaakkimainen L, et al. Evaluation of electronic medical record administrative data linked database (EMRALD). Am J Manag Care (2014) 20(1):e15–21.24669409
33. Williamson T, Green ME, Birtwhistle R, Khan S, Garies S, Wong ST, et al. Validating the 8 CPCSSN case definitions for chronic disease surveillance in a primary care database of electronic health records. Ann Fam Med (2014) 12(4):367–72.10.1370/afm.164425024246
34. Statistics Canada. Canadian Health Measures Survey - Cholesterol Levels of Canadians, Cycle 2 Data; 2009 to 2011 (2014). Available from: http://www.statcan.gc.ca/pub/82-626-x/82-626-x2013001-eng.pdf
35. Statistics Canada. Canadian Health Measures Survey – Cholesterol Levels of Canadians, Cycle 2 Data; 2007 to 2009 (2014). Available from: http://www.statcan.gc.ca/pub/82-623-x/2010002/t055-eng.htm
36. Lee S, Godwin M, Aubrey K, Collins K, Duke P, Asghari S, (2012). Rural-Urban Differences in Prevalence of Dyslipidemia in Newfoundland: Finding from Eastern Health Laboratory Information System. St. John’s, NF: Primary Care Partnership Forum.
37. Leeper NJ, Heidenreich PA. Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol. J Am Coll Cardiol (2008) 51(1):49–55.10.1016/j.jacc.2007.07.08618174036
38. Farsang C, Naditch-Brule L, Perlini S, Zidek W, Kjeldsen SE, GOOD investigators. Inter-regional comparisons of the prevalence of cardiometabolic risk factors in patients with hypertension in Europe: the GOOD survey. J Hum Hypertens (2009) 23(5):316–24.10.1038/jhh.2008.13619005476
39. Hertz RP, Unger AN, Ferrario CM. Diabetes, hypertension, and dyslipidemia in Mexican Americans and non-Hispanic whites. Am J Prev Med (2006) 30(2):103–10.10.1016/j.amepre.2005.10.01516459207